145 related articles for article (PubMed ID: 21650047)
1. [Production and immunogenicity analysis of conformation-stable fragment-C mutant of tetanus toxin].
Yu R; Hou L; Liu S; Yu C; Zhang X; Liu Y; Chen W
Sheng Wu Gong Cheng Xue Bao; 2011 Feb; 27(2):226-32. PubMed ID: 21650047
[TBL] [Abstract][Full Text] [Related]
2. [Production of recombinant fragments of the Clostridium tetani neurotoxin for the development of new immune-prophylaxis preparations against tetanus].
Varfolomeeva NA; Makhotina OA; Sergeeva TI; Belyĭ IuF
Mol Gen Mikrobiol Virusol; 2003; (3):29-33. PubMed ID: 12966924
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of tetanus toxin fragment C in Escherichia coli with thioredoxin and its evaluation as an effective subunit vaccine candidate.
Yu YZ; Gong ZW; Ma Y; Zhang SM; Zhu HQ; Wang WB; Du Y; Wang S; Yu WY; Sun ZW
Vaccine; 2011 Aug; 29(35):5978-85. PubMed ID: 21718736
[TBL] [Abstract][Full Text] [Related]
4. [Gene cloning, optimized expression and immunogenicity evaluation of tetanus toxin fragment C].
Wang MY; Zhang YN; Lei M; Zuo DM; Zhang LY; Chen ZL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):731-5. PubMed ID: 18504192
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of soluble recombinant tetanus neurotoxin Hc in Escherichia coli as a tetanus vaccine candidate.
Yu R; Hou L; Yu C; Liu S; Ren J; Fang T; Zhang X; Chen W
Immunobiology; 2011 Apr; 216(4):485-90. PubMed ID: 20888666
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis.
Norton PM; Brown HW; Wells JM; Macpherson AM; Wilson PW; Le Page RW
FEMS Immunol Med Microbiol; 1996 Jun; 14(2-3):167-77. PubMed ID: 8809553
[TBL] [Abstract][Full Text] [Related]
7. Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli.
Fairweather NF; Lyness VA; Maskell DJ
Infect Immun; 1987 Nov; 55(11):2541-5. PubMed ID: 3312002
[TBL] [Abstract][Full Text] [Related]
8. Expression and Purification of Tetanus Toxin Fragment C in Escherichia coli BL21(DE3).
Chai P; Pu X; Li J; Xia X; Ge J; Luo A; Su H; Zhang W; Ma J
Protein Pept Lett; 2020; 27(11):1132-1140. PubMed ID: 32484098
[TBL] [Abstract][Full Text] [Related]
9. Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines.
Qazi O; Sesardic D; Tierney R; Söderbäck Z; Crane D; Bolgiano B; Fairweather N
Infect Immun; 2006 Aug; 74(8):4884-91. PubMed ID: 16861677
[TBL] [Abstract][Full Text] [Related]
10. Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein.
Boucher P; Sato H; Sato Y; Locht C
Infect Immun; 1994 Feb; 62(2):449-56. PubMed ID: 7507893
[TBL] [Abstract][Full Text] [Related]
11. Generation of plant-derived recombinant DTP subunit vaccine.
Brodzik R; Spitsin S; Pogrebnyak N; Bandurska K; Portocarrero C; Andryszak K; Koprowski H; Golovkin M
Vaccine; 2009 Jun; 27(28):3730-4. PubMed ID: 19464556
[TBL] [Abstract][Full Text] [Related]
12. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis.
Robinson K; Chamberlain LM; Schofield KM; Wells JM; Le Page RW
Nat Biotechnol; 1997 Jul; 15(7):653-7. PubMed ID: 9219268
[TBL] [Abstract][Full Text] [Related]
13. Sm14 of Schistosoma mansoni in fusion with tetanus toxin fragment C induces immunoprotection against tetanus and schistosomiasis in mice.
Abreu PA; Miyasato PA; Vilar MM; Dias WO; Ho PL; Tendler M; Nascimento AL
Infect Immun; 2004 Oct; 72(10):5931-7. PubMed ID: 15385496
[TBL] [Abstract][Full Text] [Related]
14. A single-dose cytomegalovirus-based vaccine encoding tetanus toxin fragment C induces sustained levels of protective tetanus toxin antibodies in mice.
Tierney R; Nakai T; Parkins CJ; Caposio P; Fairweather NF; Sesardic D; Jarvis MA
Vaccine; 2012 Apr; 30(20):3047-52. PubMed ID: 22414558
[TBL] [Abstract][Full Text] [Related]
15. Expression of tetanus toxin fragment C in yeast: gene synthesis is required to eliminate fortuitous polyadenylation sites in AT-rich DNA.
Romanos MA; Makoff AJ; Fairweather NF; Beesley KM; Slater DE; Rayment FB; Payne MM; Clare JJ
Nucleic Acids Res; 1991 Apr; 19(7):1461-7. PubMed ID: 2027754
[TBL] [Abstract][Full Text] [Related]
16. High-level Expression of Tetanus Toxin Fragment C in Escherichia coli.
Aghaiypour K; Teymourpour R
Arch Razi Inst; 2018 Dec; 73(1):27-38. PubMed ID: 30256036
[TBL] [Abstract][Full Text] [Related]
17. Immunization of mice with poliovirus replicons expressing the C-fragment of tetanus toxin protects against lethal challenge with tetanus toxin.
Porter DC; Wang J; Moldoveanu Z; McPherson S; Morrow CD
Vaccine; 1997 Feb; 15(3):257-64. PubMed ID: 9139483
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, heat stability and safety of intranasally administered Bacillus subtilis spore or vegetative cell vaccines expressing tetanus toxin fragment C.
Lee S; Belitsky BR; Brown DW; Brinker JP; Kerstein KO; Herrmann JE; Keusch GT; Sonenshein AL; Tzipori S
Vaccine; 2010 Sep; 28(41):6658-65. PubMed ID: 20709005
[TBL] [Abstract][Full Text] [Related]
19. Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge.
Wells JM; Wilson PW; Norton PM; Gasson MJ; Le Page RW
Mol Microbiol; 1993 Jun; 8(6):1155-62. PubMed ID: 8361360
[TBL] [Abstract][Full Text] [Related]
20. Cloning and expression of functional fragment C of tetanus toxin.
Halpern JL; Habig WH; Neale EA; Stibitz S
Infect Immun; 1990 Apr; 58(4):1004-9. PubMed ID: 2318526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]